I don't think the CEO's newsletter will come out until Friday. This way he can provide an update on how GMV is received at the big Medical Conference. Lets hope there is a lot of interest from other countries not already on the GMV's band wagon.
There are a lot of share holders eager to glean whatever information that can be provided by Dr Yacov and his team.
These are the following updates that I am interested in:
a. Chinese approvals for the Prizma Sleeve & Patch and readiness of the Factory
b. FDA for the Patch in USA
c. TGA for Patch in Australia
d. Startup of IDTL in USA.
e. Will a capital raise will be needed, and
f. Anything in the pipeline for Nth America.
Its quite exhaustive and I would love to spend 1hr listening to Dr Yacov tell his own story with this little baby of his. I have watched the 40 min interview with Dr Yacov at least 5 times and I can just feel how excited he is to bring this whole idea of his to market.
I for will be along for the ride and I can't wait for the factory approval so we can get this whole show on the road.
GTLAH
Cheers Rubes
GMV Price at posting:
28.5¢ Sentiment: Buy Disclosure: Held